MedPath

成都通德药业有限公司

Ownership
-
Established
1987-08-28
Employees
-
Market Cap
-
Website
www.cd-tdyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

121

NMPA:121

Drug Approvals

Carbetocin Injection

Product Name
卡贝缩宫素注射液
Approval Number
国药准字H20249083
Approval Date
Oct 16, 2024
NMPA

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20243019
Approval Date
Jan 9, 2024
NMPA

Lacosamide Injection

Product Name
拉考沙胺注射液
Approval Number
国药准字H20243016
Approval Date
Jan 9, 2024
NMPA

Propacetamol Hydrochloride

Product Name
盐酸丙帕他莫
Approval Number
国药准字H20080567
Approval Date
Aug 23, 2023
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20066753
Approval Date
Aug 20, 2021
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H51021213
Approval Date
Mar 30, 2021
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H51021215
Approval Date
Mar 30, 2021
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H51021402
Approval Date
Mar 30, 2021
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H51021400
Approval Date
Mar 30, 2021
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H51021217
Approval Date
Mar 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.